colitis/headache

リンクがクリップボードに保存されます

記事臨床試験特許

ソートタイプを選択

ページ 1 から 189 結果

Studies of ulcerative colitis. IV. The significance of headaches.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

[A new antiserotonin agent in the treatment of asthma, headache, urticaria, severe colitis and rheumatic diseases].

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

Headache in a patient with ulcerative colitis.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

Cyclosporine in the treatment of severe steroid refractory ulcerative colitis: a retrospective analysis of 24 cases.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

BACKGROUND Cyclosporine A (CsA) has been found to be the first successful therapy used in the recovery of patients with steroid-refractory ulcerative colitis (UC). However, the long-term benefits of cyclosporine remain questionable. We report our results on the use of CsA in patients with severe

Probiotics for maintenance of remission in ulcerative colitis.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

BACKGROUND Ulcerative colitis is a chronic relapsing disease characterised by diffuse mucosal inflammation limited to the colon. Current maintenance treatments have multiple adverse events and an effective treatment with minimal adverse events is desired. Several studies have demonstrated the

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

BACKGROUND The efficacy and safety of combination therapy with adalimumab (ADA) plus intensive granulocyte and monocyte adsorptive apheresis (GMA) (two sessions per week) for the treatment of refractory ulcerative colitis (UC) have not been previously evaluated. METHODS This retrospective study

The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

OBJECTIVE This study was designed to identify the impact chronic ulcerative colitis (UC) has on the lives of patients compared to other chronic conditions. Overall, 451 patients with UC, 309 with rheumatoid arthritis, 305 with asthma, and 305 with migraine headaches were recruited in an Internet

Neuropathy and primary headaches affect different subgroups of inflammatory bowel disease patients

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

Background: Peripheral neuropathies (PN) and primary headaches (PH) are common comorbidities in inflammatory bowel disease (IBD) patients. We aimed to evaluate whether PN and PH affect the same subgroups of IBD patients.

Interventions for treating lymphocytic colitis.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

Lymphocytic colitis is a cause of chronic diarrhea. It is a subtype of microscopic colitis characterized by chronic, watery, non-bloody diarrhea and normal endoscopic and radiologic findings. The etiology of this disorder is unknown.Therapy is based mainly on case series and uncontrolled trials, or

Cerebral arteriopathy with extracranial artery involvement in a patient with ulcerative colitis.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

Arteriopathy of the central nervous system (CNS) complicated with ulcerative colitis is a rare condition, moreover the involvement of extracranial arteries has not been documented. An 18-year-old female complained of a severe pulsatile headache and nausea. She had been diagnosed and treated for

Long-term safety and tolerability of once-daily mesalamine granules in the maintenance of remission of ulcerative colitis.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

BACKGROUND Ulcerative colitis (UC), a chronic, relapsing, and remitting inflammatory bowel disease, requires long-term treatment to maintain remission. In this study, the long-term safety and tolerability of mesalamine granules (MG) therapy was evaluated in the maintenance of UC remission. Previous

Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

OBJECTIVE A capsule formulation of mesalamine granules (MG) was developed for once-daily dosing and better compliance. The study aim was to evaluate MG efficacy and tolerability in maintaining ulcerative colitis (UC) remission. METHODS Pooled analysis of 2 identical phase 3, randomized, double-blind

Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

OBJECTIVE : A multicenter, double-blind study was conducted to evaluate the safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate ulcerative colitis (UC). METHODS : Sixty-eight patients, 5 to 17 years of age, with mild-to-moderate active UC based on the

Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trial.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

The safety and efficacy of olsalazine sodium was compared to sulfasalazine over 3 months in a multicenter, randomized, double-blind study of 56 children with mild to moderate ulcerative colitis. Twenty-eight children received 30 mg/kg/day of olsalazine (maximum, 2 g/day) and 28 received 60 mg/kg/day

Campylobacter jejuni pancolitis mimicking idiopathic ulcerative colitis.

登録ユーザーのみが記事を翻訳できます

ログインサインアップ

Campylobacter jejuni is the most common cause of community-acquired acute bacterial diarrhea. Campylobacter diarrhea is usually accompanied by fever and abdominal pain. Campylobacter diarrhea is usually watery. Nausea, vomiting, headache, and myalgias may also be present. Tenesmus is a common

Facebookページに参加する

Herbal & Natural Medicine

科学に裏打ちされた最も完全な薬草データベース

55の言語で動作します
科学に裏打ちされたハーブ療法
画像によるハーブの認識
インタラクティブGPSマップ-場所にハーブをタグ付け（近日公開）
検索に関連する科学出版物を読む
それらの効果によって薬草を検索する
あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています